2023
Hepatopancreatobiliary malignancies: time to treatment matters
Kerekes D, Frey A, Bakkila B, Johnson C, Becher R, Billingsley K, Khan S. Hepatopancreatobiliary malignancies: time to treatment matters. Journal Of Gastrointestinal Oncology 2023, 0: 0-0. PMID: 37201090, PMCID: PMC10186552, DOI: 10.21037/jgo-22-1067.Peer-Reviewed Original ResearchTreatment initiationStage IHPB cancersStage I pancreatic cancerExtrahepatic bile duct cancerKaplan-Meier survival analysisHPB cancer patientsNational Cancer DatabaseRetrospective cohort studyBile duct cancerMedian treatment initiationHepatopancreatobiliary cancersMedian survivalCohort studyDuct cancerOverall survivalHispanic patientsEHBD cancerOncologic careBile ductCox regressionBlack raceCancer patientsDefinitive carePancreatic cancer
2019
Who Undergoes Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Appendiceal Cancer? An Analysis of the National Cancer Database
Byrne RM, Gilbert EW, Dewey EN, Herzig DO, Lu KC, Billingsley KG, Deveney KE, Tsikitis VL. Who Undergoes Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Appendiceal Cancer? An Analysis of the National Cancer Database. Journal Of Surgical Research 2019, 238: 198-206. PMID: 30772678, DOI: 10.1016/j.jss.2019.01.039.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsAppendiceal NeoplasmsChemotherapy, AdjuvantChemotherapy, Cancer, Regional PerfusionCytoreduction Surgical ProceduresDatabases, FactualFemaleHumansHyperthermia, InducedKaplan-Meier EstimateMaleMiddle AgedNeoadjuvant TherapyRetrospective StudiesSex FactorsTreatment OutcomeUnited StatesConceptsPerioperative intraperitoneal chemotherapyAppendiceal cancerCytoreductive surgeryIntraperitoneal chemotherapyTreatment modalitiesNational Cancer Database dataMultivariate logistic regression analysisNational Cancer DatabasePatterns of careLow-grade tumorsNon-Hispanic ethnicityLogistic regression analysisMucinous malignanciesSystemic chemotherapyMultimodality treatmentClinical factorsImproved survivalPatient selectionMale sexKaplan-MeierPatient cohortCancer DatabaseWhite raceTreatment groupsChemotherapy
2016
Nomogram for Predicting Overall Survival and Salvage Abdominoperineal Resection for Patients with Anal Cancer
Tsikitis VL, Lu KC, Kim JS, Billingsley KG, Thomas CR, Herzig DO. Nomogram for Predicting Overall Survival and Salvage Abdominoperineal Resection for Patients with Anal Cancer. Diseases Of The Colon & Rectum 2016, 59: 1-7. PMID: 26651105, DOI: 10.1097/dcr.0000000000000507.Peer-Reviewed Original ResearchSalvage abdominoperineal resectionAbdominoperineal resectionOverall survivalAnal cancerSalvage surgeryNodal statusTumor sizeStratified Cox proportional hazards modelCox proportional hazards modelAnal cancer treatmentNational Cancer DatabaseRetrospective cohort studyAnal cancer patientsYear of diagnosisTNM clinical stagePredicting Overall SurvivalOverall survival modelProportional hazards modelLogistic regression modelsSphincter preservationChemoradiation therapyCohort studySurgery statusChemoradiotherapy treatmentClinical stage
2014
Nomogram for predicting overall and colostomy-free survival for patients with anal cancer.
Tsikitis V, Lu K, Kim J, Billingsley K, Thomas C, Herzig D. Nomogram for predicting overall and colostomy-free survival for patients with anal cancer. Journal Of Clinical Oncology 2014, 32: 400-400. DOI: 10.1200/jco.2014.32.3_suppl.400.Peer-Reviewed Original ResearchColostomy-free survivalNational Cancer DatabaseAnal cancerNodal statusTumor sizeStratified Cox proportional hazards modelCox proportional hazards modelPrimary end pointRadical surgical treatmentTNM clinical stageProportional hazards modelOutcome prediction toolLogistic regression modelsCancer ptsChemoradiotherapy approachSphincter preservationAbdominoperineal resectionFree survivalSurgical treatmentSurgery statusClinical stageTNM stageCancer DatabaseHazards modelEnd point